These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 31398086)
1. Gene therapy research for kidney diseases. Davis L; Park F Physiol Genomics; 2019 Sep; 51(9):449-461. PubMed ID: 31398086 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Gene Delivery to the Kidney by Adenovirus, Adeno-Associated Virus, and Lentiviral Vectors After Intravenous and Direct Kidney Injections. Rubin JD; Nguyen TV; Allen KL; Ayasoufi K; Barry MA Hum Gene Ther; 2019 Dec; 30(12):1559-1571. PubMed ID: 31637925 [TBL] [Abstract][Full Text] [Related]
3. Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes. Kalesnykas G; Kokki E; Alasaarela L; Lesch HP; Tuulos T; Kinnunen K; Uusitalo H; Airenne K; Yla-Herttuala S Curr Gene Ther; 2017; 17(3):235-247. PubMed ID: 28982327 [TBL] [Abstract][Full Text] [Related]
4. Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium. Park SW; Kim JH; Park WJ; Kim JH J Vis Exp; 2015 Aug; (102):e53030. PubMed ID: 26274541 [TBL] [Abstract][Full Text] [Related]
5. [Developments in gene delivery vectors for ocular gene therapy]. Khabou H; Dalkara D Med Sci (Paris); 2015 May; 31(5):529-37. PubMed ID: 26059304 [TBL] [Abstract][Full Text] [Related]
7. Gene therapy of the central nervous system: general considerations on viral vectors for gene transfer into the brain. Serguera C; Bemelmans AP Rev Neurol (Paris); 2014 Dec; 170(12):727-38. PubMed ID: 25459120 [TBL] [Abstract][Full Text] [Related]
8. Viral Vectors for Gene Therapy: Translational and Clinical Outlook. Kotterman MA; Chalberg TW; Schaffer DV Annu Rev Biomed Eng; 2015; 17():63-89. PubMed ID: 26643018 [TBL] [Abstract][Full Text] [Related]
10. Adenovirus and adeno-associated virus mediated gene transfer. Kremer EJ; Perricaudet M Br Med Bull; 1995 Jan; 51(1):31-44. PubMed ID: 7767647 [TBL] [Abstract][Full Text] [Related]
11. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model. Björklund A; Kirik D; Rosenblad C; Georgievska B; Lundberg C; Mandel RJ Brain Res; 2000 Dec; 886(1-2):82-98. PubMed ID: 11119690 [TBL] [Abstract][Full Text] [Related]
12. A Review of Gene Therapy Delivery Systems for Intervertebral Disc Degeneration. Chen S; Luo M; Kou H; Shang G; Ji Y; Liu H Curr Pharm Biotechnol; 2020; 21(3):194-205. PubMed ID: 31749423 [TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus vectors for gene therapy: more pros than cons? Monahan PE; Samulski RJ Mol Med Today; 2000 Nov; 6(11):433-40. PubMed ID: 11074369 [TBL] [Abstract][Full Text] [Related]
14. Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications. Schön C; Biel M; Michalakis S Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):343-52. PubMed ID: 25615882 [TBL] [Abstract][Full Text] [Related]
17. Adeno-Associated Virus (AAV) as a Vector for Gene Therapy. Naso MF; Tomkowicz B; Perry WL; Strohl WR BioDrugs; 2017 Aug; 31(4):317-334. PubMed ID: 28669112 [TBL] [Abstract][Full Text] [Related]
18. A realistic chance for gene therapy in the near future. Worgall S Pediatr Nephrol; 2005 Feb; 20(2):118-24. PubMed ID: 15549408 [TBL] [Abstract][Full Text] [Related]
19. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells. Shayakhmetov DM; Carlson CA; Stecher H; Li Q; Stamatoyannopoulos G; Lieber A J Virol; 2002 Feb; 76(3):1135-43. PubMed ID: 11773389 [TBL] [Abstract][Full Text] [Related]